Latest Strategy News

Industrial Minerals Ltd reports encouraging progress in its High Purity Quartz projects, including promising testwork results and strategic marketing efforts in China, supported by a recent $2.3 million capital raise.

Kore Potash has signed a landmark $1.929 billion fixed-price EPC contract for its Kola Potash Project, reinforcing its strategy to become a low-cost producer. The company is now awaiting a financing proposal from the Summit Consortium expected by February 2025.

Hawthorn Resources has completed a pivotal Pre-Feasibility Study for its Mt Bevan Magnetite project and strategically converted its equity stake into a royalty, positioning the company for future value capture amid evolving market dynamics.

High Peak Royalties has fully repaid its US$750,000 financing facility with Macquarie Bank, removing all associated securities and guarantees. The company signals confidence in its near-term liquidity and operational funding.

Tempest Minerals reports maiden drilling success at its Remorse target, revealing significant high-grade magnetite and base metal anomalies with an initial exploration target of up to 110 million tonnes at 30-32% iron.

Recharge Metals has completed the acquisition of the Carter Uranium Project in Montana, USA, adding significant high-grade uranium resources to its portfolio and appointing a seasoned uranium expert to its board.

Atlantic Lithium has cleared critical regulatory hurdles for its Ewoyaa Lithium Project in Ghana, securing key permits and raising A$10 million to advance construction plans. The company also updated its feldspar resource estimate, underscoring the project's growing commercial potential.

NewPeak Metals has acquired the Allaru Vanadium Project in Queensland, marking a strategic pivot into critical minerals, supported by a planned $2–3 million capital raise via rights issue.

Equity Story Group Ltd (ASX:EQS) reports a robust December quarter marked by significant growth in funds under management, membership fees, and capital markets revenue, alongside strategic cost reductions positioning the company for sustained 2025 growth.

EVE Health Group has completed the sale of its Robyndale tea tree property and relaunched its postbiotic concentrate range, signaling a strategic shift towards innovation and growth in the Australian market.

Warriedar Resources has nearly doubled its gold resource at the Ricciardo Project to 947.5 koz and uncovered promising antimony mineralisation, backed by strong metallurgical test results and a recent A$9.55 million capital raise.

Codeifai Limited has terminated its exclusive licence with MIT and launched a strategic review of its material science division, signaling a decisive pivot towards digital and AI-driven brand solutions.